Cuál es el precio por Genix Pharmaceuticals Corporation (GENPF)

Precio por Genix Pharmaceuticals Corporation (GENPF) es de$0.0138

Cuál es la capitalización de mercado por Genix Pharmaceuticals Corporation (GENPF)

Capitalización de mercado por Genix Pharmaceuticals Corporation (GENPF) es $844.89K

Genix Pharmaceuticals Corporation (GENPF) Desdoblamientos de Acciones

Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
Not enough data for the provided dates.

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

Not enough data for the provided dates.

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País